Home Newsfeeds Cleveland Research Downgrades Salesforce to Neutral

Cleveland Research Downgrades Salesforce to Neutral

Cleveland Research downgrades Salesforce (NYSE:CRM) from Buy to Neutral.

byBenzinga Newsdesk

September 28, 2022

1 minute read

Cleveland Research downgrades Salesforce (NYSE:CRM) from Buy to Neutral.

Around $100M Bet On Zillow Group? Check Out These 3 Stocks Insiders Are Buying

By Avi Kapoor

June 12, 8:45 AM

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. When insiders purchase shares,…

DLX

Amazon’s Project Kuiper Satellites Could Be Coming To This Highly Populated Country Soon In Battle With Starlink

By Chris Katje

July 21, 10:34 AM

E-commerce giant Amazon.com Inc (NASDAQ: AMZN) has been building up a satellite internet service over the years. Here’s a look at where its Project Kuiper could soon be launching.

AMZN

Regeneron/Sanofi’s Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation

By Vandana Singh

January 26, 9:53 AM

FDA approves Dupixent (dupilumab) by Regeneron/Sanofi for pediatric eosinophilic esophagitis treatment. Breakthrough treatment for young patients.

REGN

Windtree Therapeutics Announces Publication From Its SEISMiC Pre Cardiogenic Shock Study Comparing Two Doses of Istaroxime

By Happy Mohamed

Yesterday, 8:15 AM

Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT) is a biotechnology company focused on advancing late-stage interventions for acute cardiovascular disorders of acute heart

WINT

Cleveland Research Downgrades Salesforce to Neutral

Related Posts

Around $100M Bet On Zillow Group? Check Out These 3 Stocks Insiders Are Buying

Amazon’s Project Kuiper Satellites Could Be Coming To This Highly Populated Country Soon In Battle With Starlink

Regeneron/Sanofi’s Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation

Windtree Therapeutics Announces Publication From Its SEISMiC Pre Cardiogenic Shock Study Comparing Two Doses of Istaroxime